Infex Therapeutics
PrivateLast Round
VC Round
May 12, 2026
Total Funding Raised
$2.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Infex Therapeutics operates in Healthcare & Life Sciences and is based in Alderley Edge. Its latest recorded funding round was a VC Round in May 2026.
Infex Therapeutics is a biotechnology company that acquires, develops, and licenses innovative drugs to treat pandemic and critical priority infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infex Therapeutics Comparables
Compare Infex Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revagenix, Inc. | 79% | |
| VenatoRx Pharmaceuticals | 78% | |
| Centauri Therapeutics Limited | 77% |
For institutional investors. Book with your work email.
Infex Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 12, 2026 | ||||
| Grant | Feb 17, 2025 | ||||
| Grant | Aug 8, 2022 | ||||
| VC Round | Mar 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Infex Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| Innovate UK | Grant |
| LifeArc | VC Round |
| Catapult Ventures | VC Round |
| Catapult Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 7, representing 29% of headcount.
- May 12, 2026
$5.8M round led by Jon Moulton
For institutional investors. Book with your work email.
Infex Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Infex Therapeutics's valuation, stock price, and market status.
Is Infex Therapeutics a public or private company?
Infex Therapeutics is a private company.
What is the current stock price of Infex Therapeutics?
Infex Therapeutics is a private company, so its shares have no public market price. Caplight tracks Infex Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Infex Therapeutics worth (valuation)?
Valuation information for Infex Therapeutics is not publicly available.
Can I buy Infex Therapeutics stock?
Infex Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Infex Therapeutics's last funding round?
Infex Therapeutics's most recent funding round was VC Round on May 12, 2026.
Who are the main investors in Infex Therapeutics?
Key investors in Infex Therapeutics include LifeArc.
Will Infex Therapeutics IPO soon?
No public IPO plans have been announced for Infex Therapeutics.
How can I track Infex Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Infex Therapeutics's shares on secondary markets.